1 study on Immunomodulatory mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This robust and expanding patenting activity unequivocally underscores the escalating commercial and clinical interest in thymosin peptides as a promising class of therapeutics. The identification of rapidly emerging …